O'Hara RM Jr - Search Results

1

Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer.

Malapelle U, Leighl N, Addeo A, Hershkovitz D, Hochmair MJ, Khorshid O, Länger F, de Marinis F, Peled N, Sheffield BS, Smit EF, Viteri S, Wolf J, Venturini F, O'Hara RM Jr, Rolfo C. Malapelle U, et al. Among authors: o hara rm jr. Br J Cancer. 2024 Jul;131(2):212-219. doi: 10.1038/s41416-024-02709-4. Epub 2024 May 15. Br J Cancer. 2024. PMID: 38750115 Free PMC article. Review.

2

Non-small cell lung cancer with MET amplification: review of epidemiology, associated disease characteristics, testing procedures, burden, and treatments.

Yang M, Mandal E, Liu FX, O'Hara RM Jr, Lesher B, Sanborn RE. Yang M, et al. Among authors: o hara rm jr. Front Oncol. 2024 Jan 11;13:1241402. doi: 10.3389/fonc.2023.1241402. eCollection 2023. Front Oncol. 2024. PMID: 38273845 Free PMC article.

3

Diagnosis, testing, treatment, and outcomes among patients with advanced non-small cell lung cancer in the United States.

Yang M, MacEwan JP, Boppudi SS, McClain MR, O'Hara RM Jr, Paik PK. Yang M, et al. Among authors: o hara rm jr. Cancer Med. 2023 Dec;12(24):21605-21614. doi: 10.1002/cam4.6694. Epub 2023 Dec 7. Cancer Med. 2023. PMID: 38062905 Free PMC article.

4

Selective CD28 blockade attenuates acute and chronic rejection of murine cardiac allografts in a CTLA-4-dependent manner.

Zhang T, Fresnay S, Welty E, Sangrampurkar N, Rybak E, Zhou H, Cheng XF, Feng Q, Avon C, Laaris A, Whitters M, Nagelin AM, O'Hara RM Jr, Azimzadeh AM. Zhang T, et al. Among authors: o hara rm jr. Am J Transplant. 2011 Aug;11(8):1599-609. doi: 10.1111/j.1600-6143.2011.03624.x. Epub 2011 Jul 12. Am J Transplant. 2011. PMID: 21749640 Free PMC article.

5

Cell-surface and cytokine biomarkers in autoimmune and inflammatory diseases.

O'Hara RM Jr, Benoit SE, Groves CJ, Collins M. O'Hara RM Jr, et al. Drug Discov Today. 2006 Apr;11(7-8):342-7. doi: 10.1016/j.drudis.2006.02.009. Drug Discov Today. 2006. PMID: 16580976 Review.

6

The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1.

Donaldson DD, Whitters MJ, Fitz LJ, Neben TY, Finnerty H, Henderson SL, O'Hara RM Jr, Beier DR, Turner KJ, Wood CR, Collins M. Donaldson DD, et al. Among authors: o hara rm jr. J Immunol. 1998 Sep 1;161(5):2317-24. J Immunol. 1998. PMID: 9725226

7

Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (IL)-12 antagonist IL-12(p40)2.

Rothe H, O'Hara RM Jr, Martin S, Kolb H. Rothe H, et al. Among authors: o hara rm jr. Diabetologia. 1997 Jun;40(6):641-6. doi: 10.1007/s001250050728. Diabetologia. 1997. PMID: 9222642

8

Prevention of a Th1 disease by a Th1 cytokine: IL-12 and diabetes in NOD mice.

O'Hara RM Jr, Henderson SL, Nagelin A. O'Hara RM Jr, et al. Ann N Y Acad Sci. 1996 Oct 31;795:241-9. doi: 10.1111/j.1749-6632.1996.tb52673.x. Ann N Y Acad Sci. 1996. PMID: 8958935

9

T cell receptor alpha-chain defines the antigen specificity of antigen-specific suppressor factor but does not impart genetic restriction.

O'Hara RM Jr, Byrne MC, Kuchroo VK, Nagelin A, Whitters MJ, Jayaraman S, Henderson SL, Dorf ME, Collins M. O'Hara RM Jr, et al. J Immunol. 1995 Mar 1;154(5):2075-81. J Immunol. 1995. PMID: 7868884

10

Antigen-specific suppressor factor: missing pieces in the puzzle.

O'Hara RM Jr. O'Hara RM Jr. Immunol Res. 1995;14(4):252-62. doi: 10.1007/BF02935623. Immunol Res. 1995. PMID: 8722042 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters